Published in J Am Acad Dermatol on May 01, 2007
Risk of melanoma and nonmelanoma skin cancer among patients with inflammatory bowel disease. Gastroenterology (2012) 1.97
Roles of the immune system in skin cancer. Br J Dermatol (2011) 1.12
Development of primary malignant melanoma during treatment with a TNF-α antagonist for severe Crohn's disease: a case report and review of the hypothetical association between TNF-α blockers and cancer. Drug Des Devel Ther (2013) 0.99
Regression of advanced melanoma upon withdrawal of immunosuppression: case series and literature review. Med Oncol (2009) 0.88
More questions than answers: a call for a moratorium on the use of intravitreal infliximab outside of a well-designed trial. Retina (2010) 0.87
Targeted treatment of psoriasis with adalimumab: a critical appraisal based on a systematic review of the literature. Biologics (2009) 0.79
Nodular progression of lentigo malignant melanoma during a treatment with tocilizumab: cause or coincidence? Clin Rheumatol (2012) 0.79
Nodal Melanoma Metastasis under Infliximab Therapy in a Patient with Nevoid Melanoma First Misdiagnosed as Benign Nevus: A Potentially Dangerous Diagnostic Pitfall in the Era of Biologic Therapies. Case Rep Dermatol (2013) 0.77
Association of melanoma and natalizumab therapy in the Italian MS population: a second case report. Neurol Sci (2010) 0.76
Long-term use of adalimumab in the treatment of moderate to severe plaque psoriasis: a review of the literature. Clin Cosmet Investig Dermatol (2010) 0.75
TNF inhibitors to treat ulcerative colitis in a metastatic breast cancer patient: a case report and literature review. World J Gastroenterol (2014) 0.75
Anti-TNF agents in patients with inflammatory bowel disease and malignant melanoma-challenges in management. Int J Colorectal Dis (2015) 0.75
Interstitial granulomatous drug reaction to anakinra. J Am Acad Dermatol (2008) 1.85
Superficial bladder cancer metastatic to the lungs: two case reports and review of the literature. Urology (2008) 1.53
The significance of tumor persistence after incomplete excision of basal cell carcinoma. J Am Acad Dermatol (2002) 1.52
Anogenital dermatitis in patients referred for patch testing: retrospective analysis of cross-sectional data from the North American Contact Dermatitis Group, 1994-2004. Arch Dermatol (2008) 1.49
Iodopropynyl butylcarbamate. Am J Contact Dermat (2002) 1.42
Mind the gap. Arch Dermatol (2006) 1.40
The relationship of vehicle and concentration of imidazolidinylurea, with attention to formaldehyde allergy status. Dermatitis (2006) 1.40
Effects of commercially available soy products on PSA in androgen-deprivation-naïve and castration-resistant prostate cancer. South Med J (2011) 1.39
Cystic basal cell carcinoma or hidrocytoma? The use of an excisional biopsy in a histopathologically challenging case. Am J Dermatopathol (2004) 1.18
Patients' attitudes toward medical student participation in a dermatology clinic. J Am Acad Dermatol (2003) 1.17
Increased incidence of melanoma in renal transplantation recipients. Cancer (2005) 1.17
Allergy to cocamidopropyl betaine and amidoamine in North America. Dermatitis (2004) 1.13
Delayed-type hypersensitivity to lidocaine. Arch Dermatol (2003) 1.08
North American Contact Dermatitis Group Patch Test Results: 2013-2014. Dermatitis (2016) 1.07
More evidence that genetic profiling will delineate the nosology and biologic potential of fibrohistiocytic tumors in the dermatofibrosarcoma protuberans spectrum. J Am Acad Dermatol (2013) 1.07
North American Contact Dermatitis Group patch-test results, 2001-2002 study period. Dermatitis (2004) 1.06
Effect of the tyrosine kinase inhibitors (sunitinib, sorafenib, dasatinib, and imatinib) on blood glucose levels in diabetic and nondiabetic patients in general clinical practice. J Oncol Pharm Pract (2010) 1.06
Primary mucinous carcinoma in a 54-year-old man. J Am Acad Dermatol (2003) 1.05
Xp11 translocation renal cell carcinoma: delayed but massive and lethal metastases of a chemotherapy-associated secondary malignancy. Urology (2007) 1.03
Alopecia mucinosa: report of a case and review. J Cutan Med Surg (2002) 1.02
Cutaneous CD34+ spindle cell neoplasms: Histopathologic features distinguish spindle cell lipoma, solitary fibrous tumor, and dermatofibrosarcoma protuberans. Am J Dermatopathol (2010) 1.00
Case reports and a review of the literature on ulcers mimicking pyoderma gangrenosum. Int J Dermatol (2003) 0.98
Shoe allergens: retrospective analysis of cross-sectional data from the north american contact dermatitis group, 2001-2004. Dermatitis (2007) 0.96
Final report of the safety assessment of methylisothiazolinone. Int J Toxicol (2010) 0.91
Contact allergy in children referred for patch testing: North American Contact Dermatitis Group data, 2001-2004. Arch Dermatol (2008) 0.91
Pseudoacromegaly induced by the long-term use of minoxidil. J Am Acad Dermatol (2003) 0.90
The diameter of melanomas. Dermatol Surg (2004) 0.89
The utility of digital clinical photographs in dermatopathology. J Cutan Med Surg (2004) 0.89
Spa contact dermatitis. Dermatitis (2008) 0.89
Multiple familial trichoepitheliomas: a folliculosebaceous-apocrine genodermatosis. Am J Dermatopathol (2002) 0.89
Allergic patch test reactions associated with cosmetics: retrospective analysis of cross-sectional data from the North American Contact Dermatitis Group, 2001-2004. J Am Acad Dermatol (2008) 0.88
Predicting therapy response in live tumor cells isolated with the flexible micro spring array device. Cell Cycle (2013) 0.88
Final report of the safety assessment of hyaluronic acid, potassium hyaluronate, and sodium hyaluronate. Int J Toxicol (2009) 0.88
Sebaceous carcinoma, basal cell carcinoma, trichoadenoma, trichoblastoma, and syringocystadenoma papilliferum arising within a nevus sebaceus. Dermatol Surg (2004) 0.87
Neoadjuvant concurrent chemoradiation for advanced esthesioneuroblastoma: a case series and review of the literature. J Clin Oncol (2011) 0.87
Lichen sclerosus of the lip. Pediatr Dermatol (2006) 0.86
North American Contact Dermatitis Group patch-test results, 2003-2004 study period. Dermatitis (2008) 0.86
Persistent melanocytic nevi: a review and analysis of 205 cases. J Cutan Pathol (2011) 0.86
Phase I study of detoxified Escherichia coli J5 lipopolysaccharide (J5dLPS)/group B meningococcal outer membrane protein (OMP) complex vaccine in human subjects. Vaccine (2003) 0.85
The value of patch testing patients with a scattered generalized distribution of dermatitis: retrospective cross-sectional analyses of North American Contact Dermatitis Group data, 2001 to 2004. J Am Acad Dermatol (2008) 0.85
Scleromyxedema presenting with neurologic symptoms: a case report and review of the literature. Cutis (2010) 0.85
Cutaneous B-cell lymphoma with loss of CD20 immunoreactivity after rituximab therapy. J Cutan Pathol (2003) 0.84
Basal cell carcinoma characteristics as predictors of depth of invasion. J Am Acad Dermatol (2012) 0.84
Final report of the Cosmetic Ingredient Review Expert Panel safety assessment of polymethyl methacrylate (PMMA), methyl methacrylate crosspolymer, and methyl methacrylate/glycol dimethacrylate crosspolymer. Int J Toxicol (2011) 0.83
Collagenous spherulosis in an oral mucous cyst. J Cutan Pathol (2008) 0.83
Patch-testing North American lip dermatitis patients: data from the North American Contact Dermatitis Group, 2001 to 2004. Dermatitis (2008) 0.83
The vanishing biopsy: the trend toward smaller specimens. Cutis (2005) 0.83
Erdheim-Chester disease. J Cutan Med Surg (2002) 0.82
Pressurized pulse irrigation with saline reduces surgical-site infections following major hepatobiliary and pancreatic surgery: randomized controlled trial. World J Surg (2014) 0.82
Positive patch-test reactions to mixed dialkyl thioureas: cross-sectional data from the North American Contact Dermatitis Group, 1994 to 2004. Dermatitis (2008) 0.82
Cdc7 expression in melanomas, Spitz tumors and melanocytic nevi. J Cutan Pathol (2009) 0.82
A congenital case of circumscribed acral hypokeratosis. Pediatr Dermatol (2011) 0.82
Durable complete responses off all treatment in patients with metastatic malignant melanoma after sequential immunotherapy followed by a finite course of BRAF inhibitor therapy. Cancer Biol Ther (2015) 0.82
North American Contact Dermatitis Group patch test results: 2009 to 2010. Dermatitis (2013) 0.82
Safety of ingredients used in cosmetics. J Am Acad Dermatol (2005) 0.82
Dermal dendritic cells in psoriasis, nummular dermatitis, and normal-appearing skin. J Am Acad Dermatol (2011) 0.81
Detection of nickel sensitivity has increased in North American patch-test patients. Dermatitis (2008) 0.81
Final report of the Cosmetic Ingredient Review Expert Panel amended safety assessment of Calendula officinalis-derived cosmetic ingredients. Int J Toxicol (2010) 0.81
An SV40 VP1-derived epitope recognized by CD8+ T cells is naturally processed and presented by HLA-A*0201 and cross-reactive with human polyomavirus determinants. Virology (2008) 0.81
Current and future trials of targeted therapies in cutaneous melanoma. Adv Exp Med Biol (2013) 0.81
Contact dermatitis of the hands: cross-sectional analyses of North American Contact Dermatitis Group Data, 1994-2004. J Am Acad Dermatol (2007) 0.81
Positive patch test reactions in older individuals: retrospective analysis from the North American Contact Dermatitis Group, 1994-2008. J Am Acad Dermatol (2011) 0.81
Localized chronic fibrosing vasculitis causing a rhinophymatous eruption. Cutis (2006) 0.81
Therapeutic approach guided by genetic alteration: use of MTOR inhibitor in renal medullary carcinoma with loss of PTEN expression. Cancer Biol Ther (2015) 0.81
Impact of genetic targets on cancer therapy: hepatocellular cancer. Adv Exp Med Biol (2013) 0.81
Relationship of occupation to contact dermatitis: evaluation in patients tested from 1998 to 2000. Am J Contact Dermat (2002) 0.80
Final report of the amended safety assessment of sodium laureth sulfate and related salts of sulfated ethoxylated alcohols. Int J Toxicol (2010) 0.80
Final report of the safety assessment of Kojic acid as used in cosmetics. Int J Toxicol (2010) 0.80
Final report of the safety assessment of allantoin and its related complexes. Int J Toxicol (2010) 0.80
Combined Merkel cell carcinoma and atypical fibroxanthoma. J Cutan Med Surg (2005) 0.80
North American contact dermatitis group patch test results: 2011-2012. Dermatitis (2015) 0.79
Patch testing in children from 2005 to 2012: results from the North American contact dermatitis group. Dermatitis (2014) 0.79
Pimecrolimus cream 1%: a potential new treatment for chronic hand dermatitis. Cutis (2004) 0.79
Final amended safety assessment of hydroquinone as used in cosmetics. Int J Toxicol (2010) 0.79
Significant activity of single agent vinorelbine against small-cell cancer of the bladder as second line chemotherapy: a case series and review of the literature. Urol Oncol (2010) 0.79
Occupation-related contact dermatitis in North American health care workers referred for patch testing: cross-sectional data, 1998 to 2004. Dermatitis (2008) 0.79
Unsuccessful high dose IL-2 therapy followed immediately by near continuous low dose temozolomide can result in rapid durable complete and near-complete remissions in metastatic melanoma. Cancer Biol Ther (2010) 0.79
Effects of immunomodulatory agents on patch testing: expert opinion 2012. Dermatitis (2012) 0.79
Use of the left renal vein as a practical conduit in superior mesenteric vein reconstruction. J Surg Res (2007) 0.79
Safety assessment of borosilicate glasses as used in cosmetics. Int J Toxicol (2013) 0.78
Contact dermatitis associated with food: retrospective cross-sectional analysis of North American Contact Dermatitis Group data, 2001-2004. Dermatitis (2008) 0.78
Combined anti-CD40 conditioning and well-timed immunization prolongs CD8+ T cell accumulation and control of established brain tumors. J Immunother (2008) 0.78
CD10-positive myxofibrosarcomas: a pitfall in the differential diagnosis of atypical fibroxanthoma. J Cutan Pathol (2010) 0.78
Occupational contact dermatitis in hairdressers/cosmetologists: retrospective analysis of north american contact dermatitis group data, 1994 to 2010. Dermatitis (2012) 0.78
Targeting of vaccinia virus using biotin-avidin viral coating and biotinylated antibodies. J Surg Res (2005) 0.78
North American Contact Dermatitis Group patch test results for 2007-2008. Dermatitis (2013) 0.77
The effect of race and ethnicity on patch test results. J Am Acad Dermatol (2002) 0.77
Final report on the safety assessment of Piper methysticum leaf/root/stem extract and Piper methysticum root extract. Int J Toxicol (2009) 0.77
Guillain-Barré syndrome after use of alemtuzumab (Campath) in a patient with T-cell prolymphocytic leukemia: a case report and review of the literature. Leuk Res (2010) 0.77
Pulmonary crystal-storing histiocytosis diagnosed by computed tomography-guided fine-needle aspiration. Diagn Cytopathol (2010) 0.77
Patch-test reactions to topical anesthetics: retrospective analysis of cross-sectional data, 2001 to 2004. Dermatitis (2008) 0.77
Patch-test reactions to formaldehydes, bioban, and other formaldehyde releasers. Dermatitis (2007) 0.77
Safety assessment of decyl glucoside and other alkyl glucosides as used in cosmetics. Int J Toxicol (2013) 0.77
"PTCH"-ing it together: a basal cell nevus syndrome review. Dermatol Surg (2013) 0.77
The Hershey access clinic: a model for improving patient access. J Am Acad Dermatol (2007) 0.77
Trichoblastic carcinoma associated with multiple familial trichoepithelioma. Dermatol Surg (2012) 0.77
Sensitivity of petrolatum and aqueous vehicles for detecting allergy to imidazolidinylurea, diazolidinylurea, and DMDM hydantoin: a retrospective analysis from the North American Contact Dermatitis Group. Dermatitis (2007) 0.77